Abstract:OBJECTIVE:To investigate the early changes and clinical significance of plasma endothelin (ET), nitric oxide (NO) and arginine-vasopressin (AVP) in patients with acute moderate or severe cerebral injury. METHODS:The early (at 24 hours after injury) plasma concentrations of ET, NO and AVP were measured with radioimmunoassay and Green technique in 48 cases of acute moderate (GCS8 in 21 cases) cerebral injury (Group A), in 42 cases of non-cerebral injury (Group B) and in 38 normal individuals (Group C), respectively. RESULTS:The early plasma concentrations of ET (109.73 ng/L+/-12.61 ng/L), NO (92.82 micromol/L+/-18.21 micromol/L ) and AVP (49.78 ng/L+/-14.29 ng/L) in Group A were higher than those in Group B (67.90 ng/L+/-11.33 ng/L, 52.66 micromol/L+/-12.82 micromol/L and 29.93 ng/L+/-12.11 ng/L, respectively, P<0.01) and Group C (50.65 ng/L+/-17.12 ng/L, 36.12 micromol/L+/-2.16 micromol/L and 5.18 ng/L+/-4.18 ng/L, respectively, P<0.001 ). The amounts of ET, NO and AVP in patients with severe cerebral injury were 116.18 ng/L+/-18.12 ng/L, 108.19 micromol/L+/-13.28 micromol/L and 58.13 ng/L+/-16.78 ng/L, respectively, which were significantly higher than that of the patients with moderate cerebral injury (92.33 ng/L+/-16.32 ng/L, 76.38 micromol/L+/-12.71 micromol/L and 36.18 ng/L+/-12.13 ng/L respectively, P<0.01 ). The early levels of ET, NO and AVP in Group A were negatively related to the GCS scales. The amounts of ET, NO and AVP were 126.23 ng/L+/-15.23 ng/L, 118.18 micromol/L+/-10.12 micromol/L and 63.49 ng/L+/-14.36 ng/L respectively in patients with subdural hematoma, which were significantly higher than those in patients with epidural hematoma (81.13 ng/L+/-12.37 ng/L, 68.02 micromol/L+/-13.18 micromol/L and 45.63 ng/L+/-12.41 ng/L respectively, P<0.01). The plasma concentrations of ET, NO and AVP in stable duration (at 336 hours after injury) in Group A and Group B were similar to those in Group C. CONCLUSIONS:ET, NO and AVP were related to the pathophysiological process that occurs in the early stage of acute cerebral injury and the values of ET, NO and AVP correlate positively with the clinical manifestations. The changes of plasma ET, NO and AVP can be regarded as important indices to assess the severity of acute cerebral injury.

The Significance of the Monitoring of IL-6 and Nenron Specific Enolase for Acute Surgical Brain Injury

Serum Neuron Specific Enolase and Matrix Metalloproteinases in Patients with Severe Traumatic Brain Injury and the Clinical Significance

Significance of serum neuron-specific enolase in assessment of severity of brain damage and its correlation with Glascow Coma Scale score

The Influence of Acupuncture on Serum IL-6 and NSE Levels after Encephaloma Operation

Research of Serum Neuron-specific Enolase to Evaluate the Prognosis of Severe Head Injury

Early Changes of Endothelin, Nitric Oxide and Arginine-Vasopressin in Patients with Acute Cerebral Injury.

The Dynamic Change of Neuron Specific Enolase Following Acute Brain Injury in Rats

Evaluation of severe brain injury prognosis by neuron-specific enolase, myelin basic protein

Lactic Acid, Neuron-Specific Enolase, and Blood-Brain Barrier Index after a Severe Traumatic Brain Injury: a Prospective Study

[Effects of Propofol and Isoflurane on Serum Neuron-Specific Enolase Level in Surgical Patients with Acute Craniocerebral Trauma: a Comparative Study].

Effect of Propofol on Serum NSE Concentration and MMSE Score after Operation in Patients with Cerebral Injury Undergoing Neurosurgery

Effect of Small Amount of Mannitol on Serum Neuron-specific Enolase in Patients with Acute Cerebral Infarction

Clinical Significance of Neuron Specific Enolase and S100 Beta Protein in Intracranial Infection and Brain Injury.

S-100B and Neuron Specific Enolase in Outcome Prediction of Severe Head Injury

Relationship between cerebrospinal fluidα-Synuclein and prognosis of patients with traumatic brain injury

Dynamic Change in Serum Levels of NSE and Its Relattonship with ICP, CPP and the Prognosis in Patients with Craniocerebral Injury

Clinical study of serum Mg～(2+) and NSE levels in patients with traumatic subarachnoid hemorrhage

Dynamic change of peripheral blood glial fibrillary acidic protein (GFAP) and neurospecifie enolase (NSE) in patients with craniocerebral injury

Measurement of serum neuron-specific enolase levels in patients with acute stroke

Change in levels of serum NSE in brain death patients

The predictive value of S-100B and NSE in outcome of patients with severe head injury